CMPS COMPASS Pathways Plc American Depository Shares : Bullish and Bearish Analyst Opinions
Sentiment & Price
▼
Sentiment Gauge
1
Bull
0
Bear
0
Watch
Bull 100%
Bear 0%
Price & Sentiment
long
short
neutral
— click post dots to open
Loading chart...
Recent News
Top Views ▼
No recent news for CMPS
No theses available
Feed
05:43
Apr 19
Apr 19
Compass Pathways (CMPS) is listed as one of the author's holdings poised to benefit from accelerated psychedelic therapy approvals. The author's logic is that sector-wide positive news will lift all boats in the psychedelic biotech space. A generic long bet on the sector, tied to a vague political headline. CMPS has its own clinical trial risks. The post's catalyst is not specific to CMPS. Stock performance may not correlate with political news.
MED
18:29
Mar 15
Mar 15
The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.
About CMPS Analyst Coverage
Buzzberg tracks CMPS (COMPASS Pathways Plc American Depository Shares) across 2 sources. 1 bullish vs 1 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked.